Global Influenza Vaccine Market is projected to cross more than US$ 5 Billion
26 Sep, 2017

Influenza Vaccine is also known as flu in the shot and is used for guard against influenza virus. An influenza vaccine is a mixture of 3 influenza viruses i.e. type A with H3N2 virus strain, influenza type A with H1N1 virus strain and influenza type B virus strain. Global Influenza Vaccine Market is projected to cross more than US$ 5 Billion.
  
In the recent H1N1 pandemic seems to have brought in a never-before acceptance towards vaccination for flu. The number of adults who took the vaccine raised this year compared to the last year, say vaccine manufacturing companies.

Get Free 10% Customization in This Report

Access full Research:   http://www.renub.com/global-influenza-vaccine-market-and-forecast-30-countries-market-and-vaccinated-population-data-by-pediatrics-and-adult-and-vaccine-brands-analysis-1081-p.php

The influenza virus has been a concern in infecting millions of people on yearly basis. With the vaccination programs against influenza infections necessitating has to manufacture million doses within a very short span of time. The innovative production systems based on insect cell cultures or mammalian have resulted in overcoming the challenges associated with the egg-based production system.

The range of influenza vaccines is formed in fertilized eggs, the origin of which is infected in order that the virus can reproduce. The production is complex and missing in the event of a pandemic because of the prospect of generating low yields, not being willing to rapidly expand and being dependent on the availability of eggs. Worldwide authorities have recognized the problems related with manufacturing vaccines based on eggs, resulting in creating a need for developing alternative vaccine production systems. Currently authorities have been facilitating on the growth of manufacturing systems based on bacteria, plants, cell cultures and yeast. 

Request a free sample copy of the report: http://www.renub.com/contactus.php

Now let’s see the different types of Influenza Viruses A B C & D

Influenza type A

Influenza A viruses is categorized into subtypes which are based on two proteins on the surface of the virus: the Hemagglutinin (H) and the Neuraminidase (N). Further, the Hemagglutinin (H) is categorized into 18 different subtypes and the Neuraminidase (N) is of 11 different subtypes. 

Influenza A viruses can be categorized into different strains. In the current scenario the subtypes of influenza A viruses were found in people are influenza A (H1N1) and influenza A (H3N2) viruses. If we resemble the scenario of the year 2009 in the spring, a new influenza A (H1N1) virus appears to cause illness in people. At that time that virus was very different from the human influenza A (H1N1) viruses on circulation. Around more than 40 years, the new virus caused the first influenza pandemic. That virus often known as “2009 H1N1” has now replaced by H1N1 virus that was circulating in humans previously.

Influenza Type B

Influenza B viruses are not categorized into subtypes, but can be further split into strains and lineages. In the current scenario circulating influenza B viruses belong to one of two lineages: B/Victoria and B/Yamagata.

Influenza type C

Influenza type C infections generally cause a mild respiratory illness and are not thought to cause epidemics.

Influenza type D

Influenza D viruses primarily affect cattle and are not known to infect or cause illness in people.

A look at Global Influenza Vaccine Market Share & its Impact globally

According to Renub Research, Worldwide Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but at the same time was considerably less than the Adult Influenza Vaccinated Population. As per our research, Pediatrics Influenza Vaccinated population will fall down in coming years and Adult Influenza Vaccinated Population will rise in the anticipated period.

In Global Influenza Vaccine Market, United States leads the market share among other countries. The United States Influenza Vaccine Market Share was 4 times more than China & Japan Influenza Vaccine Market Share. In Pediatrics Influenza Vaccine Market Share, the United States & China together captures almost 60 percent market. On the other hand, in adult vaccination segments approximately 50 percent of the market share is expected to be captured by the United States and Japan by the projected the year 2022. 

Our research has found that in Europe Influenza vaccine market, The United Kingdom dominates the seasonal influenza vaccine market share followed by Germany and France respectively. The United Kingdom also led in children vaccination followed by France at number second. In adult vaccination, for the top spot close fight between the United Kingdom and Germany.

In the Baltic Countries Influenza vaccine market, Lithuania dominates the seasonal influenza vaccine market share followed by Latvia and Estonia. In the year 2016, in children vaccination, around 70 percent market share captured by Lithuania & Latvia whereas, in adult vaccination segments, more than 95 percent market share is captured by Lithuania & Latvia by the forecasted period of 2022.

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research

Phone: +1-678-302-0700

Email: info@renub.com

Website: http://www.renub.com     

Follow us on LinkedIn: http://www.linkedin.com/company/renub-research